Stock listing
NYSE American:RGNT Regentis Biomaterials Ltd. Stock
Home listing (NYSE American) of Regentis Biomaterials Ltd.
Follow Regentis Biomaterials Ltd. into a list and get an email when it puts out news.
Share price · AMEX:RGNT
$1.37 USD +0.01 (+0.7%)
Close on Oct 30, 2026
- Day range
- $1.31 – $1.42 USDOct 30, 2026
- Volume
- 24,869 sharesOct 30, 2026
- Market cap
- $9.62M USDAt the close on Oct 30, 2026 · price × 7.02M shares outstanding
- Traded on an average day
- $97,044 USDMedian day 28,200 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:RGNT · Home | $1.37 USD | +0.01 (+0.7%) | 24,869 | $1.42 | $1.42 | $1.31 | $1.36 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · AMEX:RGNT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.37 | +0.01 | +0.7% | $1.42 | $1.42 | $1.31 | 24,869 | |
| $1.36 | +0.13 | +10.6% | $1.28 | $1.47 | $1.265 | 61,901 | |
| $1.23 | -0.06 | -4.7% | $1.26 | $1.30 | $1.23 | 17,646 | |
| $1.29 | +0.03 | +2.4% | $1.27 | $1.415 | $1.25 | 27,098 | |
| $1.26 | -0.02 | -1.6% | $1.30 | $1.32 | $1.26 | 25,202 | |
| $1.28 | -0.12 | -8.6% | $1.42 | $1.42 | $1.28 | 18,400 | |
| $1.40 | -0.09 | -6.0% | $1.48 | $1.48 | $1.40 | 50,700 | |
| $1.49 | +0.02 | +1.4% | $1.51 | $1.559 | $1.484 | 14,200 | |
| $1.47 | -0.01 | -0.7% | $1.53 | $1.54 | $1.47 | 13,800 | |
| $1.48 | -0.01 | -0.7% | $1.44 | $1.60 | $1.44 | 36,100 | |
| $1.49 | -0.06 | -3.9% | $1.60 | $1.60 | $1.46 | 23,500 | |
| $1.55 | +0.04 | +2.6% | $1.55 | $1.56 | $1.50 | 14,300 | |
| $1.51 | -0.115 | -7.1% | $1.65 | $1.65 | $1.45 | 132,600 | |
| $1.625 | -0.005 | -0.3% | $1.63 | $1.67 | $1.59 | 33,400 | |
| $1.63 | +0.03 | +1.9% | $1.62 | $1.645 | $1.60 | 36,100 | |
| $1.60 | -0.10 | -5.9% | $1.67 | $1.74 | $1.60 | 22,200 | |
| $1.70 | +0.07 | +4.3% | $1.69 | $1.73 | $1.65 | 172,800 | |
| $1.63 | -0.02 | -1.2% | $1.64 | $1.69 | $1.63 | 17,000 | |
| $1.65 | -0.02 | -1.2% | $1.67 | $1.74 | $1.65 | 34,000 | |
| $1.67 | -0.18 | -9.7% | $1.83 | $1.86 | $1.66 | 109,500 | |
| $1.85 | +0.02 | +1.1% | $1.85 | $1.874 | $1.78 | 29,000 | |
| $1.83 | +0.02 | +1.1% | $1.86 | $1.88 | $1.80 | 9,000 | |
| $1.81 | -0.04 | -2.2% | $1.87 | $1.98 | $1.81 | 22,200 | |
| $1.85 | -0.04 | -2.1% | $1.92 | $1.92 | $1.80 | 58,600 | |
| $1.89 | -0.09 | -4.5% | $1.95 | $1.97 | $1.855 | 7,600 | |
| $1.98 | -0.06 | -2.9% | $2.06 | $2.08 | $1.90 | 17,200 | |
| $2.04 | -0.06 | -2.9% | $2.08 | $2.08 | $2.00 | 25,000 | |
| $2.10 | +0.01 | +0.5% | $2.135 | $2.15 | $2.05 | 15,100 | |
| $2.09 | -0.14 | -6.3% | $2.17 | $2.17 | $2.09 | 41,200 | |
| $2.23 | +0.42 | +23.2% | $1.85 | $2.48 | $1.85 | 440,400 | |
| $1.81 | +0.06 | +3.4% | $1.80 | $1.89 | $1.73 | 22,800 | |
| $1.75 | -0.05 | -2.8% | $1.82 | $1.87 | $1.75 | 20,607 | |
| $1.80 | -0.01 | -0.6% | $1.81 | $1.85 | $1.74 | 27,400 | |
| $1.81 | -0.07 | -3.7% | $1.89 | $1.89 | $1.75 | 194,400 | |
| $1.88 | -0.01 | -0.5% | $1.90 | $1.96 | $1.875 | 16,600 | |
| $1.89 | -0.07 | -3.6% | $2.02 | $2.02 | $1.89 | 16,542 | |
| $1.96 | -0.05 | -2.5% | $2.01 | $2.01 | $1.915 | 12,800 | |
| $2.01 | -0.03 | -1.5% | $2.06 | $2.07 | $1.98 | 10,500 | |
| $2.04 | +0.07 | +3.6% | $2.00 | $2.04 | $1.92 | 55,800 | |
| $1.97 | 0.00 | 0.0% | $1.94 | $2.00 | $1.94 | 15,900 | |
| $1.97 | -0.05 | -2.5% | $2.06 | $2.06 | $1.94 | 54,300 | |
| $2.02 | -0.04 | -1.9% | $2.05 | $2.09 | $2.02 | 14,500 | |
| $2.06 | +0.02 | +1.0% | $2.04 | $2.11 | $2.005 | 38,500 | |
| $2.04 | +0.04 | +2.0% | $2.00 | $2.14 | $2.00 | 24,400 | |
| $2.00 | -0.06 | -2.9% | $2.10 | $2.10 | $2.00 | 19,636 | |
| $2.06 | -0.01 | -0.5% | $2.12 | $2.12 | $2.06 | 8,200 | |
| $2.07 | -0.02 | -1.0% | $2.08 | $2.155 | $2.04 | 19,100 | |
| $2.09 | -0.07 | -3.2% | $2.10 | $2.14 | $2.00 | 19,800 | |
| $2.16 | +0.06 | +2.9% | $2.15 | $2.18 | $1.96 | 25,600 | |
| $2.10 | +0.04 | +1.9% | $2.05 | $2.17 | $2.05 | 37,200 | |
| $2.06 | -0.17 | -7.6% | $2.14 | $2.22 | $2.06 | 46,000 | |
| $2.23 | +0.24 | +12.1% | $2.00 | $2.47 | $1.98 | 197,700 | |
| $1.99 | -0.05 | -2.5% | $1.99 | $2.03 | $1.95 | 51,600 | |
| $2.04 | +0.04 | +2.0% | $2.04 | $2.065 | $2.01 | 51,000 | |
| $2.00 | +0.10 | +5.3% | $1.91 | $2.03 | $1.90 | 55,100 | |
| $1.90 | -0.04 | -2.1% | $1.96 | $2.01 | $1.90 | 29,300 | |
| $1.94 | +0.10 | +5.4% | $1.80 | $1.97 | $1.80 | 45,600 | |
| $1.84 | -0.01 | -0.5% | $1.86 | $1.93 | $1.82 | 41,896 | |
| $1.85 | -0.04 | -2.1% | $1.84 | $1.905 | $1.80 | 19,900 | |
| $1.89 | -0.08 | -4.1% | $2.04 | $2.04 | $1.855 | 43,400 | |
| $1.97 | -0.10 | -4.8% | $2.06 | $2.06 | $1.97 | 36,400 | |
| $2.07 | +0.01 | +0.5% | $2.06 | $2.27 | $1.98 | 112,300 | |
| $2.06 | +0.19 | +10.2% | $1.87 | $2.149 | $1.87 | 115,700 | |
| $1.87 | +0.13 | +7.5% | $1.74 | $1.99 | $1.70 | 146,400 | |
| $1.74 | -0.06 | -3.3% | $1.79 | $1.907 | $1.73 | 128,900 | |
| $1.80 | +0.02 | +1.1% | $1.81 | $1.88 | $1.77 | 68,300 |
- Ticker
- NYSE American:RGNT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Latest news release · Oct 12, 2026
Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 23 slides
Latest news
Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal
Oct 12, 2026
Closed $1.63 (+1.9%) on Oct 12, 2026
Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Sep 11, 2026
Closed $1.89 (-3.6%) on Sep 11, 2026
Regentis Receives Japanese Patent allowance, Strengthening its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology
Jul 20, 2026
Closed $2.00 (-16.0%) on Jul 20, 2026
Regentis Biomaterials (RGNT) Receives European Approval for Next-Generation GelrinC Manufacturing Process
Jul 16, 2026
Closed $2.22 (-8.6%) on Jul 16, 2026
Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch
Jul 15, 2026
Closed $2.43 (-4.3%) on Jul 15, 2026
Regentis Biomaterials Announces Pricing of a $6.5 Million Private Placement
Jun 17, 2026
Closed $4.29 (-9.7%) on Jun 18, 2026
Regentis to Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate
Jun 8, 2026
Closed $1.28 (-3.0%) on Jun 8, 2026
Regentis Biomaterials (RGNT) Advances Simplified Cartilage Repair Platform Toward Key Commercial Milestones
Jun 1, 2026
Closed $1.63 (-11.9%) on Jun 1, 2026
Regentis Biomaterials (RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant
May 29, 2026
Closed $1.85 (-6.6%) on May 29, 2026
Amendment to Annual Report by Foreign Issuer (Form 20-F/A)
Feb 27, 2026
Closed $3.22 (-18.8%) on Mar 2, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 23 slides · September 2026
IPO Roadshow (May 2026)
IPO roadshow · 26 slides · May 29, 2026
IPO Roadshow (October 2025)
IPO roadshow · 25 slides · Oct 6, 2025
IPO Roadshow (July 2025)
IPO roadshow · 25 slides · Jul 7, 2025
Regentis Biomaterials Ltd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 12 in the last 12 months · 12 in all · newest Oct 12, 2026 · oldest 2025
- Decks
- 4 decks · latest September 2026
Where Regentis Biomaterials Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:RGNT · Home listing · This page | NYSE American | United States | USD |
| BOATS:RGNT | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Regentis Biomaterials Ltd.